REMEVi review
Names every pharmacy
The rare platform that publishes which pharmacy fills your prescription, by name and city — and bills every four weeks, not every month.
Our verdict
REMEVi publishes a page most of this category would never write: the four pharmacies that fill its prescriptions, named with cities and states, plus the statement that the dispensing pharmacy's name will appear on your vial label. Pair that with one flat $145 covering any of its six preparations, bilingual care in English and Spanish delivered by clinicians trained in both, and coverage across all 50 states and DC, and the operational disclosure here is genuinely above the board. The catch is arithmetic, not honesty: $145 per four weeks is thirteen charges a year, so it is not a monthly price, and the evidence behind four of the six preparations ranges from thin to absent.
Disclosure: Aminoscope is reader-supported. Some links below are affiliate links — if you start care through them we may earn a commission, at no extra cost to you. This never affects our rankings or verdicts. How we make money.
At a glance
- Category
- Peptide telehealth
- Access
- NAD⁺ $145 per 4-week subscription for injection, nasal spray or oral dropper; 50 states and DC, all-inclusive
- Insurance
- Cash-pay, no insurance
- Visit
- Async intake
- Availability
- All 50 states plus DC
- LegitScript
- Certified
- Updated
- July 2026
Popular alternative
Oak Longevity
Low-cost sermorelin within a broader longevity stack
Check Oak Longevity availability →What it is
REMEVi is a bilingual English-and-Spanish telehealth clinic operated by REMEVi LLC of Las Vegas, Nevada. Its cellular-optimisation line is deliberately closed rather than a catalogue: six prescribed preparations — NAD⁺ (as injection, nasal spray or oral dropper), sermorelin, B12/MIC, glutathione, methylene blue, and Lipo-C/L-carnitine. A separate GLP-1 weight-loss program runs compounded semaglutide and tirzepatide, injectable and oral. Care is described as delivered by clinicians who work in both languages rather than through auto-translation, with a network of US-licensed clinicians whose licences are stated as checked against the issuing state board and the NPI registry.
How it works
Asynchronous and provider-gated: a roughly five-minute intake in English or Spanish, review by a US-licensed provider stated as inside 24 hours, then dispensing by a state-licensed compounding pharmacy in three to five days if a prescription is appropriate. The site says plainly there is no buy-now-without-a-consult path and that a provider may decline. Two structural things stand out. The first is the pharmacy page, which names RedRock Pharmacy in St. George, Utah; Health Warehouse in Florence, Kentucky; Precision Medicine in Bellmore, New York; and Triad Rx in Daphne, Alabama, explains that prescriptions are routed to the pharmacy licensed for your state, and commits to updating the page when the network changes. Naming the dispensing pharmacy is the single most useful disclosure a platform in this category can make, and almost nobody makes it. The second is the billing cycle. REMEVi subscriptions run in four-week blocks — its own copy explains this as a beyond-use-date discipline so vials arrive inside their window — which is defensible clinically and means thirteen charges a year rather than twelve. Budget accordingly. LegitScript certification is displayed, the operating entity and a Las Vegas address are published, and content carries a named clinical reviewer with a state licence number.
Pricing transparency
One number across the whole cellular-optimisation line: $145 per four-week subscription for sermorelin, NAD⁺, glutathione, B12/MIC, methylene blue or Lipo-C/L-carnitine, stated as all-inclusive — the clinical evaluation, the prescribed medication, injection supplies and instructions, discreet shipping and a bilingual care coordinator, with no insurance billed and no membership fee. Read the cycle before the number. Four weeks is not a month; thirteen charges a year at $145 is materially more than twelve, and comparing $145 against a competitor's monthly figure without adjusting will mislead you. What is not published is dose or vial size next to the price, so "a subscription" is undefined in volume terms — ask what a shipment contains and at what concentration, since that is what actually differs between sermorelin and NAD⁺ vendors. Its GLP-1 pricing is separate and flat by dose — $219/mo for semaglutide injections falling to $149 on a 52-week prepay, $349 for oral semaglutide, $319 for tirzepatide — but those are weight-loss numbers and are not a peptide or NAD⁺ price.
Branded vs compounded
Compounded; not FDA-approved. Prescription required only if a licensed provider finds it appropriate. REMEVi states this on each product page in its own words, explains the 503A and 503B pathways plainly, and says explicitly that its compounded preparations are not generic versions of any approved drug and have not been studied as finished products — clearer than most of this board, and it still means the FDA has not reviewed those preparations for purity and potency the way it reviews approved drugs. On the evidence, the six preparations are not equivalent purchases at one price. Sermorelin is a GHRH analogue that prompts your own pituitary to release growth hormone, preserving the somatostatin feedback loop that injected HGH overrides — a real, well-characterised mechanism whose long-term human outcome data thins out badly past short-term IGF-1 changes. Injected, intranasal and oral compounded NAD⁺ have no controlled human outcome trials; the single human intravenous study was a pharmacokinetic pilot showing infused NAD⁺ clears from plasma quickly, and the forms with human trial data are the oral precursors NR and NMN, which raise blood NAD⁺ — a biomarker, not an outcome. Glutathione has essentially no controlled human outcome data behind the detoxification and skin claims attached to it. Methylene blue has a genuine approved use in methaemoglobinaemia and an interesting mitochondrial rationale, but the cognitive and longevity claims made for low-dose oral use are not supported by controlled outcome trials, and it interacts dangerously with serotonergic drugs. Individual results vary.
Pros and watch-outs
What we like
- Names all four fulfilment pharmacies with city and state, and says the pharmacy's name appears on your vial label
- One flat $145 per four-week subscription across all six preparations, all-inclusive with no membership fee
- Bilingual clinical care in English and Spanish, delivered by clinicians trained in both rather than auto-translated
- Operating entity, Las Vegas address, LegitScript certification and a named clinical reviewer with a state licence number all published
- Explicit compounded-medication disclosure on each product page, including that the preparations are not generics and have not been studied as finished products
Watch-outs
- Billing runs in four-week blocks — thirteen charges a year, not twelve, so $145 is not a monthly price
- Dose and vial size are not published beside the price, so what a subscription contains is undefined
- One flat price across six preparations whose evidence bases are not remotely comparable
- The longevity line is a closed set — no BPC-157, ipamorelin, tesamorelin or GHK-Cu route
- Press coverage cited on the site is syndicated placement rather than editorial assessment
Best for
Spanish- or English-speaking patients who want to know exactly which licensed pharmacy is filling their prescription, and who are comfortable with a four-week billing cycle.
Who should look elsewhere
Anyone comparing on a strict monthly budget, anyone who needs dose and vial size published before ordering, or anyone wanting a peptide outside its six-item line.
The evidence behind what REMEVi prescribes
We grade the molecules, not the marketing. Here is what the human data actually shows for each thing on their menu.
- Sermorelin: a real GHRH drug, read against the anti-aging pitch
An approved growth-hormone-releasing analog with a pediatric track record — and a longevity case built more on biomarkers than outcomes.
- NAD+ precursors (NR and NMN): what the human trials actually show
They raise NAD+ and look safe short-term — but human evidence is surrogate-marker level, and no trial shows they extend healthspan.
- Glutathione: the master antioxidant, and where the evidence actually is
Oral glutathione really does raise your body stores (a 6-month RCT proved it) — but the longevity and detox claims are unproven, skin-lightening is modest, and IV glutathione is the most marketed, least evidenced route. The precursors may be the smarter bet.
- Methylene blue: the longevity 'biohack' that's actually a drug
Low-dose methylene blue has a plausible mitochondrial mechanism and a real single-dose memory signal — but it's an FDA-approved drug, not a supplement, its anti-aging claims are preclinical, and it can cause fatal serotonin syndrome with antidepressants.
How REMEVi compares
A few alternatives worth a look, depending on what you’re optimizing for.
- RxION Health
A flat NAD⁺ price from a platform that says on the page what the evidence does not support
See RxION Health → - Revel Health
Comparing injected against intranasal NAD⁺ at two published prices in one place
See Revel Health → - Remi Meds
NAD⁺ buyers who want the weekly volume stated, not just a monthly fee
See Remi Meds →
Peptides & longevity · Reviewed and last verified July 2026
How we assessed this. This review reflects Aminoscope’s own read of REMEVi’s publicly-stated model — pricing transparency, clinical oversight, medication clarity, and access — against our editorial methodology. We publish no fabricated ratings or first-hand outcomes. A partnership never changes the assessment — see how we make money.
Frequently asked
- What does sermorelin cost at REMEVi?
- $145 per four-week subscription, stated as all-inclusive: the clinical evaluation by a licensed US provider, the prescribed medication from a state-licensed compounding pharmacy, injection supplies and instructions, discreet shipping and bilingual support. NAD⁺, glutathione, B12/MIC, methylene blue and Lipo-C/L-carnitine are the same price. Compounded; not FDA-approved.
- Is $145 per four weeks the same as $145 a month?
- No, and this is the single most important thing to notice. A four-week cycle bills thirteen times a year rather than twelve. REMEVi explains the cadence as a beyond-use-date discipline so each vial arrives inside its window, which is a reasonable clinical reason — but if you are comparing against a competitor's monthly price, adjust for the extra cycle.
- Which pharmacy actually fills my prescription?
- REMEVi publishes the network by name: RedRock Pharmacy in St. George, Utah; Health Warehouse in Florence, Kentucky; Precision Medicine in Bellmore, New York; and Triad Rx in Daphne, Alabama. Your prescription is routed to whichever is licensed for your state, and the site states the pharmacy's name and address appear on your vial label and shipping paperwork.
- Is the bilingual care real or a translated website?
- REMEVi's claim is that care is delivered in English or Spanish by clinicians who work in both languages, with a bilingual care coordinator through intake and follow-up, rather than machine-translated pages. It runs a full parallel Spanish site. That is a service claim we are reporting, not something we can verify from the outside — ask to be matched with a Spanish-speaking clinician at intake if it matters to you.